McDaniel College elects new members to the Board of Trustees

McDaniel College has named two new members to its Board of Trustees.

Jin Kang of Great Falls, Va., is president and chief executive officer (CEO) of WidePoint Corporation and serves as a director of the company. A serial entrepreneur, Kang has more than three decades of professional experience in mergers and acquisitions, corporate management, technology management, business development, and financial management in information technology. He is also the founder of WidePoint Integrated Solutions Corp. (formerly known as iSYS, LLC), which he started in 1999 and served as its president and CEO until 2017. Kang successfully managed the subsidiary from inception to a company with gross revenues of $24 million when acquired by WidePoint in 2008.

With a successful operations track record and proven ability to drive growth and maximize profitability of an organization, Kang is a recognized expert in the field of trusted mobility management for both the public and private sectors. Kang has held senior management positions with several of the world’s leading technology corporations as well as key leadership positions on high-profile government programs including the Combined DNA Index System, Defense Medical Information Systems/Systems Integration, Design Development, Operations and Maintenance Services, and the Defense Blood Standard System. Kang obtained his bachelor’s and master’s degrees in Computer Science and Computer Systems Management from the University of Maryland.

Susan C. Stevenson of Ashland, Mass., is a 1985 alumna of McDaniel (formerly Western Maryland) College with a bachelor’s degree in Chemistry and a minor in Biology. She played on cross country, lacrosse, outdoor track, and intramural sports teams as well as served as a member of Phi Alpha Mu sorority and the Beta Beta Beta Biology Honor Society. Stevenson is an executive director in the Exploratory Disease Area (DAx) in the Chemical Biology and Therapeutics Department at the Novartis Institutes for Biomedical Research (NIBR) in Cambridge, Mass.

With more than 30 years of experience in drug discovery in the development of multiple therapeutic modalities, Stevenson prioritizes mentoring to support the next generation of scientific leaders within Novartis as well as in the larger scientific community. She supports diversity and inclusion initiatives and employee resource groups focused on developing cross-cultural awareness and advancing women in leadership positions. In 2016, Stevenson was honored as a Novartis Leading Scientist in recognition of her leadership, innovation, and research excellence. Stevenson earned a Ph.D. in Biochemistry from Wake Forest University in Winston-Salem, N.C., followed by a post-doctoral fellowship at Columbia University in New York. At McDaniel, she will serve as a member of the academic and campus life and audit and risk committees.